Wilbanks Smith & Thomas Asset Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
Wilbanks Smith & Thomas Asset Management's AGN Position: Q2 2019 in Review
Wilbanks Smith & Thomas Asset Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 3,163 shares — an estimated $463K sold.
Wilbanks Smith & Thomas Asset Management first reported a position in AGN in Q4 2014 and held it in 14 quarters. The position peaked at $463K in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.
- Wilbanks Smith & Thomas Asset Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
- Wilbanks Smith & Thomas Asset Management sold 3,163 Allergan plc shares in Q2 2019, an estimated $463K.
- Wilbanks Smith & Thomas Asset Management first reported a position in Allergan plc in Q4 2014 and held it in 14 quarters.
- Wilbanks Smith & Thomas Asset Management's Allergan plc position peaked at $463K in Q1 2019.
- 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.
Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q2 2019, filed 7 Aug 2019.